Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation

Cytokine

Volumn 10, Issue 4, 1998, Pages 303-306

  Denizot, Yves ^a   Lorgeot, Valérie ^a   Cornu, Elisabeth ^a   Nathan, Nathalie ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cardiopulmonary bypass; CEC; IL 6; LIF; Soluble IL 6 receptor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; SEPSIS;

EID: 0032055979     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0285     Document Type: Article

References (23)

1. 1. Pearl RG, Sladen RN, Rosenthal MH (1987) Hematologic effects of cardiac and noncardiac surgery. J Cardiothorac Anesth 1:205-209.
2. 2. Casey LC (1993) Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 56:S92-S96.
3. 3. Butler J, Rocker GM, Westaby S (1993) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559.
4. 4. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23:820-824.
5. 5. Mackiewicz A, Schooltink H, Heinrich P, Rose-John S (1992) Complex of soluble human IL-6 receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 149:2021-2027.
6. 6. Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne PA (1995) Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on primary hepatocytes. Eur J Immunol 25:2378-2383.
7. 7. Frieling JTM, van Deuren M, Wijdenes J, van der Meer JWM, Clement C, van der Linden CJ, Sauerwein RW (1995) Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 171:469-472.
8. 8. Saatvedt K, Lindberg H, Michelsen S, Pedersen T, Seem E, Geiran O (1996) Release of soluble tumour necrosis factor alpha receptors during and after paediatric cardiopulmonary bypass. Correlation with haemodynamic and clinical variables. Cytokine 8:944-948.
9. 9. Baumann H, Wong GG (1989) Hepatocyte-stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 143:1163-1167.
10. 10. Mori M, Yamaguchi K, Honda S, Nagasaki K, Ueda M, Abe O, Abe K (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 51:6656-6659.
11. 11. Gearing DP, Thut CJ, Vandenbos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP (1991) Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer gp130. EMBO J 10:2839-2848.
12. 12. Heymann D, L'Her E, NGuyen JM, Raher S, Canfrère I, Coupey L, Fixe P, Chailleux E, De Groote D, Praloran V, Godard A (1996) Leukemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF). Cytokine 8:410-416.
13. 13. Villers D, Dao T, Nguyen JM, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou JP, Anegon I (1995) Increased plasma levels of human interleukin for DA1.a cells/ leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J Infect Dis 171:232-236.
14. 14. Denizot Y, Fixe P, Liozon E, Praloran V (1996) Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies. Blood 87:4016-4017.
15. 15. Lorgeot V, Praloran V, Turlure P, Denizot Y (1997) Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies. Leukemia 11:311-312.
16. 16. Kyrtsonis MC, Dedoussis G, Zervas C, Perifanis V, Baxevanis C, Stamatelou M, Maniatis A (1996) Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma. Br J Haematol 93:398-400.
17. 17. Saatvedt K, Lindberg H, Michelsen S, Mollnes TE (1996) Release of interleukin 6 and activation of complement during and after paediatric cardiopulmonary bypass. Effect of autotransfusion of shed mediastinal blood and ultrafiltration. Cytokine 8:417-420.
18. 18. Steinberg BM, Grossi EA, Schwartz DS, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, Greenwald J, Flisser A, Spencer FC, Galloway AC, Colvin SB (1995) Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 60:525-529.
19. 19. Horiuchi S, Kotanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto M, Yamamoto N (1994) Soluble interleukin-6 receptors released from T cell or granulocyte/ macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 24:1945-1948.
20. 20. Müllberg J, Schooltink H, Stoyan T, Günter M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S (1993) The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473-480.
21. 21. Denizot Y, Fixe P, Cornu E, Nathan N (1996) Plasma macrophage colony-stimulating factor levels during cardiopulmonary bypass with extracorporeal circulation. Med Inflamm 5:358-361.
22. 22. Lecron JC, Roblot P, Chevalier S, Morel P, Alderman E, Gombert J, Gascan H (1993) High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 92:23-26.
23. 23. Fixe P, Lorgeot V, Le Meur Y, Coupey L, Heymann D, Godard A, Praloran V (1996) Development of enzymoimmunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine 8:586-591.